Retained foreign bodies and associated risk factors and outcomes in pediatric surgical patients

Angelina L Schwartz1, Maziar M Nourian1, Brian T Bucher1

  • 1Division of Pediatric Surgery, Department of Surgery, University of Utah School of Medicine, 100 N. Mario Capecchi Drive, Salt Lake City, UT 84113, United States.

Insights

Retained foreign bodies (RFB) after surgery are a patient safety concern. Pediatric patients undergoing emergent procedures, especially in interventional radiology, face higher RFB risks, leading to longer hospital stays but not increased mortality.

Area of Science:

  • Pediatric Surgery
  • Patient Safety
  • Health Services Research

Background:

  • Retained foreign bodies (RFB) after surgery are recognized patient safety indicators by the Agency for Health Care Quality and Research (AHRQ).
  • Identifying pediatric-specific risk factors and outcomes associated with RFB is crucial for improving patient care.

Purpose of the Study:

  • To identify pediatric patient and procedure risk factors for retained foreign bodies (RFB).
  • To determine the outcomes associated with RFB in pediatric surgical patients.

Main Methods:

  • Retrospective case-control study utilizing the Pediatric Health Information System (PHIS) database.
  • Patients with RFB were identified using AHRQ Patient Safety Indicator (PSI) definitions.
  • Controls were matched 5:1 on age, procedure date, and hospital; secondary outcomes included length of stay and mortality.

Main Results:

  • Pediatric patients with RFB frequently had emergent procedures, chronic conditions, and required ICU admission or mechanical ventilation.
  • Musculoskeletal procedures accounted for the highest number of RFB cases (30.4%), while interventional radiology procedures showed significantly higher odds of RFB (AOR 7.88).
  • Children with RFB experienced a 4-day increase in hospital length of stay (p < .001) but no significant difference in mortality (p = .579).

Conclusions:

  • Administrative flags can be utilized to identify pediatric patients at higher risk for retained foreign bodies.
  • Early identification and prevention strategies are essential to mitigate the primary problem and sequelae of RFB in children.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Factors Affecting Body Temperature01:28

Factors Affecting Body Temperature

As a nurse, it is vital to understand the factors affecting body temperature to monitor variations and effectively evaluate deviations from regular.
Factors may  include:
9.4K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
317
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
237
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
327